Literature DB >> 15606643

Guidelines for the diagnosis of tick-borne bacterial diseases in Europe.

P Brouqui1, F Bacellar, G Baranton, R J Birtles, A Bjoërsdorff, J R Blanco, G Caruso, M Cinco, P E Fournier, E Francavilla, M Jensenius, J Kazar, H Laferl, A Lakos, S Lotric Furlan, M Maurin, J A Oteo, P Parola, C Perez-Eid, O Peter, D Postic, D Raoult, A Tellez, Y Tselentis, B Wilske.   

Abstract

Ticks are obligate haematophagous acarines that parasitise every class of vertebrate (including man) and have a worldwide distribution. An increasing awareness of tick-borne diseases among clinicians and scientific researchers has led to the recent description of a number of emerging tick-borne bacterial diseases. Since the identification of Borrelia burgdorferi as the agent of Lyme disease in 1982, 11 tick-borne human bacterial pathogens have been described in Europe. Aetiological diagnosis of tick-transmitted diseases is often difficult and relies on specialised laboratories using very specific tools. Interpretation of laboratory data is very important in order to establish the diagnosis. These guidelines aim to help clinicians and microbiologists in diagnosing infection transmitted by tick bites and to provide the scientific and medical community with a better understanding of these infectious diseases.

Entities:  

Mesh:

Year:  2004        PMID: 15606643     DOI: 10.1111/j.1469-0691.2004.01019.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  85 in total

1.  Comparison of immunofluorescence assay (IFA) and LIAISON in patients with different clinical manifestations of Lyme borreliosis.

Authors:  Tjasa Cerar; Eva Ruzic-Sabljic; Joze Cimperman; Franc Strle
Journal:  Wien Klin Wochenschr       Date:  2006-11       Impact factor: 1.704

2.  Expression and immunogenicity of recombinant immunoreactive surface protein 2 of Anaplasma phagocytophilum.

Authors:  Qiang Yu; Chuang-fu Chen; Qiang Chen; Li-juan Zhang
Journal:  Clin Vaccine Immunol       Date:  2012-04-25

3.  A serosurvey of Anaplasma phagocytophilum in blood donors in Crete, Greece.

Authors:  D Chochlakis; A Papaeustathiou; G Minadakis; A Psaroulaki; Y Tselentis
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-02-22       Impact factor: 3.267

4.  Humoral immune responses in patients with Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Franc Strle; Eva Ruzić-Sabljić
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

5.  Cerebral sinuvenous thrombosis associated with Lyme neuroborreliosis.

Authors:  Michael Adamaszek; Alexander Heinrich; Andreas Rang; Sönke Langner; Alexander V Khaw
Journal:  J Neurol       Date:  2009-11-26       Impact factor: 4.849

6.  In vitro susceptibility of Borrelia spielmanii to antimicrobial agents commonly used for treatment of Lyme disease.

Authors:  Kristina Morgenstern; Georg Baljer; Douglas E Norris; Peter Kraiczy; Christa Hanssen-Hübner; Klaus-Peter Hunfeld
Journal:  Antimicrob Agents Chemother       Date:  2008-12-15       Impact factor: 5.191

7.  Detection of Antibodies to Spotted Fever Group Rickettsiae and Arboviral Coinfections in Febrile Individuals in 2014-2015 in Southern Coastal Ecuador.

Authors:  Lorne Farovitch; Rachel Sippy; Efraín Beltrán-Ayala; Timothy P Endy; Anna M Stewart-Ibarra; Brian F Leydet
Journal:  Am J Trop Med Hyg       Date:  2019-11       Impact factor: 2.345

8.  Rickettsia slovaca in Dermacentor marginatus and tick-borne lymphadenopathy, Tuscany, Italy.

Authors:  Marco Selmi; Luigi Bertolotti; Laura Tomassone; Alessandro Mannelli
Journal:  Emerg Infect Dis       Date:  2008-05       Impact factor: 6.883

9.  Diagnosis of Queensland tick typhus and African tick bite fever by PCR of lesion swabs.

Authors:  Jin Mei Wang; Bernard J Hudson; Matthew R Watts; Tom Karagiannis; Noel J Fisher; Catherine Anderson; Paul Roffey
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

10.  Antibodies against Rickettsia spp. in hunters, Germany.

Authors:  Andreas Jansen; Bernard La Scola; Didier Raoult; Michael Lierz; Ole Wichmann; Klaus Stark; Thomas Schneider
Journal:  Emerg Infect Dis       Date:  2008-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.